We believe that AI has an important role to play in the healthcare offerings of the future. In the form of machine learning, it is the primary capability behind the development of precision medicine, widely agreed to be a sorely needed advance in care. Although early efforts at providing diagnosis and treatment recommendations have proven challenging, we expect that AI will ultimately master that domain as well. Given the rapid advances in AI for imaging analysis, it seems likely that most radiology and pathology images will be examined at some point by a machine. Speech and text recognition are already employed for tasks like patient communication and capture of clinical notes, and their usage will increase.

The greatest challenge to AI in these healthcare domains is not whether the technologies will be capable enough to be useful, but rather ensuring their adoption in daily clinical practice. For widespread adoption to take place, AI systems must be approved by regulators, integrated with EHR systems, standardised to a sufficient degree that similar products work in a similar fashion, taught to clinicians, paid for by public or private payer organisations and updated over time in the field. These challenges will ultimately be overcome, but they will take much longer to do so than it will take for the technologies themselves to mature. As a result, we expect to see limited use of AI in clinical practice within 5 years and more extensive use within 10.

It also seems increasingly clear that AI systems will not replace human clinicians on a large scale, but rather will augment their efforts to care for patients. Over time, human clinicians may move toward tasks and job designs that draw on uniquely human skills like empathy, persuasion and big-picture integration. Perhaps the only healthcare providers who will lose their jobs over time may be those who refuse to work alongside artificial intelligence.

Innovation strategies, frameworks and implementation plans for effective cutting-edge solutions in health, industry 4.0, education, organisational psychology, human capital and workplace productivity.

The group supports the emergence of ‘Consumer Directed Care’, a personalised ‘continuum of care’ model, that is now legislated (in Australia) for both disability services (NDIS) and in-home aged care.

‘Consumer Directed Care’ is our entree into ‘Value Based Care’ and Australia’s global healthcare differentiator. Getting it right, means systemic entrenched leadership across Asia-Pacific for at least the next 2-3 generations.

This new model of healthcare, whist initially disruptive, will help drive new 21st century population health practices and the underpinning next generation of assistive technology. ‘Industry 4.0’ business models and technologies will be at its core.

New systems will emerge that have our citizens with comorbidity and chronic health conditions at the centre. Rapidly converging demands will align our population health, aged care, disability services, technology and education providers into a new alliance focused on co-designing highly personalised and practical solutions from the outset.

Capacity building will be a key principle progressing along the illness, wellness and fitness spectrum.

"Maximising opportunities from new, growing and strategically important industries including renewable energy and the digital and care economies will be critical to boosting productivity, sustaining full employment and ensuring our cities and regions thrive."

The most significant structural shift of the past 20 years has been the rise of the services sector. The growth in the health and care economy has been an important part of this trend."

• The health care and social assistance sector has more than doubled in size over the past 20 years, rising from 10 to 15 per cent of the workforce and now employs more than 2 million people. Employment in the sector is projected to grow by 15.8 per cent over the next five years.

• Labour shortages in the care workforce are already acute and expected to worsen with a projected shortfall of 286,000 care workers by 2050. Low pay and challenging conditions, partly as a result of high workloads and staff absences related to COVID-19 and influenza, have led to higher staff turnover.

• The care workforce is also highly feminised. Around 9 in 10 aged care workers are women and a high number of workers come from migrant backgrounds.

Biomedical sciences are a set of sciences applying portions of natural science or formal science, or both, to develop knowledge, interventions, or technology that are of use in healthcare or public health.

Biomedical science is one of the broadest areas of modern science and underpins much of modern medicine - from determining the blood requirements of critically ill patients to identifying outbreaks of infectious diseases to monitoring biomarkers in cancer
Biomedical science staff mostly work in healthcare laboratories diagnosing diseases and evaluating the effectiveness of treatment by analysing fluids and tissue samples from patients. They provide the 'engine room' of modern medicine - 70% of diagnoses are based on pathology results provided by laboratory services.
Five amazing health research breakthroughs
• The Oxford/AstraZeneca COVID-19 Vaccine. ...
• The human liver repaired using lab-grown cells. ...
• The super effective single-dose breast cancer treatment. ...
• The steroids and arthritis drugs saving the lives of COVID-19 patients. ...
• The oral antibiotic advancing cystic fibrosis treatment.

From the electronic pacemaker (1926) and ultrasound (1961), to multi-channel cochlear implants (1970s) and a globally important cancer vaccine (1991), Australian ingenuity has given the world many medical miracles. Spray-on skin is another world-first developed in Australia.

The Digital Health CRC harnesses the power of data and digital technologies to improve health outcomes, increase efficiency in health and aged care delivery, and grow a competitive digital health industry for Australia.

The use of robots in hospitals is evolving steadily, doing everything from repetitive analytical tasks in medical analytical laboratories, cleaning and disinfecting, through to high end human-robot interaction robots applying tele-robotics for precision surgery, such as the da Vinci Surgical Robot, collaborative robots or "cobots", and telerobotic telepresence technology which enables doctors to meet patients virtually and provide telehealth services.

Antimicrobial resistance kills more people each year than COVID, and peak health bodies warn the situation will get worse unless urgent action is taken. In response, Australia’s top researchers have partnered with government and industry to find solutions to this global problem.